FTRE Competitors & Alternatives
Compare Fortrea Holdings Inc. with similar stocks in the same industry
Biotechnology
FTRE
Main Stock$13.44
Tradestie Score
56
Market Cap
$864.42M
Revenue Growth
0.0%
Analyst Upside
+20.6%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RCUS
Arcus Biosciences, Inc.
|
$23.45
|
$1.43B | - | 50 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$13.81
|
$1.42B | - | 58 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$19.49
|
$1.35B | - | 57 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$34.78
|
$1.32B | - | 57 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$6.00
|
$1.29B | 91.1 | 52 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$28.84
|
$1.29B | - | 52 | Compare |
|
ARDX
Ardelyx, Inc.
|
$6.08
|
$1.29B | - | 51 | Compare |
|
ZYME
Zymeworks Inc.
|
$24.31
|
$1.28B | - | 59 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.23
|
$1.27B | - | 60 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$38.74
|
$1.26B | - | 50 | Compare |
More FTRE Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 8071)
228 stocks in this industry